White House withdraws Heidi Overton's nomination to lead the FDA
The White House withdrew late Tuesday the nomination of Dr. Heidi Overton to lead the FDA, hours before a Senate committee was due to vote on her confirmation. It is the fourth health nomination pulled for lack of Republican support.
Overton, a physician and senior White House official, was nominated in August by Trump to replace Marty Makary, who resigned in May. To advance in the 21-member Senate Health Committee, she needed the votes of all 12 Republicans, as no Democratic support was expected.
A senior official told Axios that Overton “lacks the support on the Hill to move forward.” Committee chair Sen. Bill Cassidy, however, said on X that she “had a viable path” and that the nomination fell apart over abortion: anti-abortion lawmakers sought commitments on the abortion pill mifepristone, whose safety review ends in March 2027, and “the Administration withdrew Dr. Overton rather than make such commitments.”
Overton was also questioned over her role in revising childhood vaccination recommendations and her support for splitting the MMR vaccine into separate doses, something Cassidy called “almost disqualifying.” Figures in the “Make America Healthy Again” movement also opposed her.
The FDA, which regulates drugs, vaccines, medical devices and food, will remain without a permanent leader well into next year. It is led on an acting basis by Kyle Diamantas. The agency has lost about 20% of its staff since Trump took office.
Photo: Getty Images
Source: AP